Mirabella Financial Services LLP Cara Therapeutics, Inc. Transaction History

Mirabella Financial Services LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$2.83 - $4.94 $40,347 - $70,429	14,257 New	14,257 $40,000
Q4 2022 Feb 13, 2023	SELL	$8.88 - $12.77 $120,643 - $173,493	-13,586 Reduced 11.94%	100,194 $1.08 Million
Q3 2022 Oct 26, 2022	BUY	$8.24 - $12.56 $937,547 - $1.43 Million	113,780 New	113,780 $1.07 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.